Skip to main content
. Author manuscript; available in PMC: 2018 Mar 1.
Published in final edited form as: Clin Infect Dis. 2017 Jun 15;64(12):1678–1685. doi: 10.1093/cid/cix237

Table 1.

Background characteristics of case-patients and control-patients.

Whole population Cases Oral streptococcal IE Controls Non oral IE

265 73 (27.5%) 192 (73.4%)
N* %* N* %* N* %* p
Patients’ characteristics

Age, years (mean, SD) 60.8 16.7 55.5 17.6 62.8 15.9 0.002
 Age ≥ 65 years 123 46.4 21 28.8 102 53.1 0.001

Male sex 217 80.0 53 72.6 159 82.8 0.063
At least one comorbidity 94 35.5 15 20.5 79 41.1 0.002

Diabetes mellitus 48 18.1 9 12.3 39 20.3 0.132

Cancer 41 15.5 6 8.2 35 18.2 0.044

Dialysis 5 1.9 0 0 5 2.6 0.329

Intravenous drug use 6 2.3 0 0 6 3.1 0.019

Active smoking 51 19.8 15 21.7 36 19.0 0.631

Cardiac history

Underlying valve diseases (HD) 0.014
 Prosthetic valve 67 25.3 18 24.7 49 25.5
 Previously known native HD 76 28.1 30 41.1 46 24.0
 No previously known HD 122 46.0 25 34.2 97 50.5
Pacemaker and/or implantable cardioverter defibrillator 29 10.9 2 2.7 27 14.1 0.008

History of IE 21 7.9 7 9.6 14 7.3 0.536

Note:

*

unless otherwise specified

IE infective endocarditis

Bold value: statistically significant